Impact of tumor contrast in orthogonal ray imaging: A prostate irradiation study

Lopes, Ana Luisa; Simoes, Hugo; Crespo, Paulo; Barata, J. A. S.; Lencart, Joana; Domingues, Inês

doi:10.1109/nssmic.2016.8069392

Cited by 3 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One way to enhance the visibility of the lesion is by injecting a contrast agent. Thus, the benefit of iodinated-contrast agent incorporation into the OrthoCT images was previously evaluated [8]. The results show to be impossible to detect the tumor and the prostate in any of the studied scenarios: before and after contrast agent incorporation.…”

Section: Introductionmentioning

confidence: 99%

Patient Compton Scattered Radiation for Monitoring Prostate Radiotherapy with Gold Fiducial Markers: A Simulation Study

Lopes¹,

Simoes²,

Travassos³

et al. 2017

IJPMBS

Self Cite

View full text Add to dashboard Cite

Abstract-Orthogonal ray imaging is a new low-dose imaging technology under study aimed at assist externalbeam radiotherapy (EBRT) treatments. It consists in detecting radiation scattered in the patient and emitted perpendicularly to the incident beam. Such radiation can be collected by positioning a multi-sliced, collimator-based, 1D detector system parallel to the beam axis, hence collecting such orthogonal rays, or by using a pinhole-like detector system positioned above or below the patient. This system can potentially be useful for on-board imaging, or real-time EBRT monitoring. In terms of prostate cancer irradiation, the use of implanted fiducial markers allows a more precise verification of the gland position relative to the bony anatomy. The prostate target normally exhibits intra-and interfraction motion induced by the daily variation in rectal and bladder filling. In order to solve this issue, three gold fiducial markers are inserted into the prostate. In the present study, the imaging capability provided by utilizing X-rays escaping the patient/fiducial markers orthogonally in respect to the incoming beam direction is studied by GEANT4 simulation. The results allow concluding that the signal provided by such X-rays is highly coincident with the position of the gold fiducial markers, even in situations where these have been deviated by as little as 3.0 mm.  Index Terms-image-guided radiotherapy, OrthoCT, Monte Carlo simulation, gold fiducial markers, prostate cancer

show abstract

Section: Introductionmentioning

confidence: 99%